Emerging fungal pathogens are a threat to forest and agroecosystems, as well as animal
and human health. How pathogens evolve from nonpathogenic ancestors is still poorly …

Fungi are a major source of valuable bioactive secondary metabolites (SMs). These
compounds are synthesized by enzymes encoded by genes that are clustered in the …

Marine fungi of the genus Penicillium are rich resources of secondary metabolites, showing
a variety of biological activities. Our anti-bacterial screening revealed that the crude extract …

Penicillium expansum, the causal agent of blue mould disease, produces the mycotoxins
patulin and citrinin amongst other secondary metabolites. Secondary metabolism is …

Secondary metabolites (SMs) are a vast group of compounds with different structures and
properties that have been utilized as drugs, food additives, dyes, and as monomers for novel …

Antibiotics were derived originally from wild organisms and therefore understanding how
these compounds evolve among different lineages might help with the design of new …

Lichen-forming fungi produce a vast number of unique natural products with a wide variety
of biological activities and human uses. Although lichens have remarkable potential in …

Background Penicillium species are important producers of bioactive secondary
metabolites. However, the immense diversity of the fungal kingdom is only scarcely …

Azoles are the most commonly used clinical antifungal therapy and also play an important
role in control of plant pathogens. Intrinsic resistance to the azole class of fungicides, which …

The secondary metabolome of Penicillium nordicum is poorly documented despite its
frequent detection on contaminated food and its capacity to produce toxic metabolites such …